Bierman P - Search Results

1

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Linder J, Weisenburger D, Harrington D, Casey J, Bierman P, Sorensen S, Hutchins M, Moravec DF, et al. Armitage JO, et al. Among authors: bierman p. J Clin Oncol. 1989 Dec;7(12):1783-90. doi: 10.1200/JCO.1989.7.12.1783. J Clin Oncol. 1989. PMID: 2585020

2

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: bierman pj. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

3

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT. Armitage JO, et al. Among authors: bierman pj. Am J Med. 1991 Dec;91(6):605-11. doi: 10.1016/0002-9343(91)90213-h. Am J Med. 1991. PMID: 1750430

4

Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies.

Bierman PJ, Vose JM, Armitage JO. Bierman PJ, et al. Leukemia. 1991;5 Suppl 1:58-62. Leukemia. 1991. PMID: 1890868 No abstract available.

5

The therapy of non-Hodgkin's lymphomas. Introduction and overview.

Vose JM, Bierman PJ, Weisenburger DD, Armitage JO. Vose JM, et al. Among authors: bierman pj. Hematol Oncol Clin North Am. 1991 Oct;5(5):845-52. Hematol Oncol Clin North Am. 1991. PMID: 1938757 Review.

6

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

Vose JM, Peterson C, Bierman PJ, Weisenburger DD, Linder J, Harrington D, Vaughan WP, Kessinger A, Armitage JO. Vose JM, et al. Among authors: bierman pj. Blood. 1990 Jul 15;76(2):424-31. Blood. 1990. PMID: 1973361 Free article.

7

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

Vose JM, Bierman PJ, Anderson JR, Weisenburger D, Moravec DF, Sorensen S, Hutchins M, Dowling MD, Howe D, Okerbloom J, et al. Vose JM, et al. Among authors: bierman pj. J Clin Oncol. 1991 Aug;9(8):1421-5. doi: 10.1200/JCO.1991.9.8.1421. J Clin Oncol. 1991. PMID: 2072145

8

Salvage therapy for patients with non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Bierman PJ. Armitage JO, et al. Among authors: bierman pj. J Natl Cancer Inst Monogr. 1990;(10):39-43. J Natl Cancer Inst Monogr. 1990. PMID: 2189475 Review.

9

Hodgkin's disease: the role of bone marrow transplantation.

Vose JM, Bierman PJ, Armitage JO. Vose JM, et al. Among authors: bierman pj. Semin Oncol. 1990 Dec;17(6):749-57. Semin Oncol. 1990. PMID: 2251520 Review.

10

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, et al. Vose JM, et al. Among authors: bierman pj. J Clin Oncol. 1988 Dec;6(12):1838-44. doi: 10.1200/JCO.1988.6.12.1838. J Clin Oncol. 1988. PMID: 2462026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters